Pharmaceutical News

RSS

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

19 Oct 2010

NCCN updates Clinical Practice Guidelines for Breast Cancer

The National Comprehensive Cancer Network® (NCCN®) recently updated the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines™) for Breast Cancer to affirm the recommendation regarding the use of bevacizumab (Avastin®, Genentech/Roche) in the treatment of metastatic breast cancer.

19 Oct 2010

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced plans to pursue a U.S. label expansion for Qutenza® (capsaicin) 8% patch to include patients with painful HIV-associated neuropathy (HIV-AN, also referred to as HIV-distal sensory polyneuropathy (HIV-DSP)).

19 Oct 2010

Elorac acquires world-wide rights to Cidoxepin

Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, is pleased to announce that it has acquired world-wide rights to the active agent Cidoxepin from Gideon Pharmaceuticals. Cidoxepin is the cis-isomer of the widely prescribed tricyclic compound doxepin.

19 Oct 2010

Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the website of the U.S. Food and Drug Administration (FDA) indicates that an Abbreviated New Drug Application (ANDA) for a generic version of Silenor® (doxepin) 3 mg and 6 mg was submitted on September 16, 2010.

19 Oct 2010

Tylenol batch recalled due to strange smell

Johnson and Johnson’s (J&J) commonly used over-the-counter painkiller Tylenol has been recalled again in some batches because of complaints of a musty or moldy odor in the product. The company is facing a U.S. congressional probe of quality control lapses in the past as well. The drugs recalled to date include the painkiller Motrin and allergy treatment Benadryl as well as this batch of 100,000 bottles of Tylenol.

18 Oct 2010

STB completes Fibrin Adhesive STat pre-IND submission to FDA

STB Lifesaving Technologies® today announced that is has completed a successful pre-Investigational New Drug (pre-IND) submission to the U.S. Food and Drug Administration (FDA) for its lead product, the Fibrin Adhesive STat®, or (FAST®) dressing.

18 Oct 2010

PharmaTrust to launch third generation MedCentre remote dispensing system

PharmaTrust is launching the next generation of the MedCentre remote dispensing system with world-class features that redefine and take remote dispensing services to the next level. The MedCentre is a modular, scalable solution designed to meet both patients' need for convenience and counseling and healthcare professionals' responsibility to deliver the highest level of care.

18 Oct 2010

Lannett announces launch of Fluphenazine HCl Tablets

Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it has commenced shipping Fluphenazine HCl Tablets USP, the generic equivalent of Prolixin®, in 1 mg, 2.5 mg, 5 mg and 10 mg dosages. For the 12 months ended September 2010, Fluphenazine HCl Tablets USP, 1 mg, 2.5 mg, 5 mg, & 10 mg had U.S. sales of approximately $28 million at Average Wholesale Price.

18 Oct 2010

GeoVax Labs contributes article for HIV vaccine

Robert T. McNally, Ph.D., president and CEO of GeoVax Labs, Inc. a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has contributed an article on the search for an HIV vaccine to the October 15 issue of Genetic Engineering & Biotechnology News (GEN).

18 Oct 2010

NanoViricides' President delivers speech at ASNM Second Annual Conference

NanoViricides, Inc. announced today that the Company President was invited to and presented a talk at the Second Annual Conference of the American Society for NanoMedicine (ASNM).

18 Oct 2010

Emollient creams on eczemous skin likely to make condition worse

New research at the University of Bath suggests that using emollient creams to relieve the symptoms of eczema could actually make the condition worse.

18 Oct 2010

Biocon, Pfizer enter global agreement to commercialize Insulin analog products

Biocon, Asia's premier biotechnology company, and Pfizer Inc. (NYSE: PFE), the world's leading biopharmaceutical company, today announced that they have entered into a strategic global agreement for the worldwide commercialization of Biocon's biosimilar versions of Insulin and Insulin analog products: Recombinant Human Insulin, Glargine, Aspart and Lispro.

18 Oct 2010

Fera Pharmaceuticals launches Garamycin Ophthalmic Ointment

Fera Pharmaceuticals announced the launch today of preservative free Garamycin (gentamicin sulfate) Ophthalmic Ointment USP.

18 Oct 2010

Bend Research extends 3-year agreement with Bristol-Myers Squibb

Bend Research Inc. a leading independent technology-based drug-formulation development and manufacturing organization, announced today it has extended its drug discovery enablement and development services agreement with Bristol-Myers Squibb Company, a global biopharmaceutical company.

18 Oct 2010

Intellipharmaceutics announces FDA acceptance to file ANDA for Protonix generic version

Intellipharmaceutics International Inc. today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of Protonix (delayed release pantoprazole sodium).

18 Oct 2010

Researchers to develop technologies that can mask horrid taste of children's medicines

A spoonful of sugar is the traditional way to help medicines 'go down'. But getting young children to take foul-tasting medicines - even if their lives depend on it - requires more than a bit of added sweetener. According to the World Health Organisation (WHO), each year over eight million children die of diseases that could be avoided if essential medicines were available in appropriate formulations for children.

18 Oct 2010

Study finds correlation between flu vaccination and Medicaid reimbursement rates

Increasing the amount that physicians are reimbursed by Medicaid for administering influenza shots may raise vaccination rates among poor children. That is the conclusion of a study published online today in the journal Pediatrics.

18 Oct 2010

Phase III study influences WHO to change guidelines for HIV-infected women receiving nevirapine

Findings from a study, which appear in the Oct. 14, 2010 New England Journal of Medicine, helped influence the World Health Organization (WHO) to change its guidelines this year for the treatment of HIV-infected women who receive a single dose of the antiretroviral drug nevirapine to prevent HIV transmission to their babies.

18 Oct 2010

New discovery raises hopes for women with tamoxifen resistance

SCIENTISTS in London have found a potential new way of boosting the effectiveness of the anti-breast cancer drug, tamoxifen.

18 Oct 2010

Pharmaceutical News

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

NCCN updates Clinical Practice Guidelines for Breast Cancer

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

Elorac acquires world-wide rights to Cidoxepin

Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA

Tylenol batch recalled due to strange smell

STB completes Fibrin Adhesive STat pre-IND submission to FDA

PharmaTrust to launch third generation MedCentre remote dispensing system

Lannett announces launch of Fluphenazine HCl Tablets

GeoVax Labs contributes article for HIV vaccine

NanoViricides' President delivers speech at ASNM Second Annual Conference

Emollient creams on eczemous skin likely to make condition worse

Biocon, Pfizer enter global agreement to commercialize Insulin analog products

Fera Pharmaceuticals launches Garamycin Ophthalmic Ointment

Bend Research extends 3-year agreement with Bristol-Myers Squibb

Intellipharmaceutics announces FDA acceptance to file ANDA for Protonix generic version

Researchers to develop technologies that can mask horrid taste of children's medicines

Study finds correlation between flu vaccination and Medicaid reimbursement rates

Phase III study influences WHO to change guidelines for HIV-infected women receiving nevirapine

New discovery raises hopes for women with tamoxifen resistance

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News